First‐Pass Uptake of Verapamil, Diazepam, and Thiopental in the Human Lung

The first-pass uptake of verapamil, diazepam, and thiopental in the human lung was determined using multiple-indicator dilution techniques. These three drugs represent lipid-soluble agents that differ in their ionic characteristics at physiological pH. Verapamil, a basic lipophilic amine, underwent significant uptake, with 50% of the drug accumulating in lung tissue during the first pass. With diazepam, a nonbasic lipophilic amine, there was 30% uptake during the first pass through the human lung-significantly less than that observed with verapamil. With thiopental, an acidic lipophilic barbiturate, only 14% of the injected drug accumulated in the lung during the first pass. Taken together, these data are consistent with observations from animal studies, which indicate that extensive pulmonary uptake is greater with basic amine drugs that are moderately to highly lipid-soluble. Also, the relatively high first-pass uptake of verapamil in the human lung suggests a quantitatively significant role of this nonrespiratoy function of the lung in the early pharmacokinetics of intravenous verapamil.

[1]  K. Piafsky Disease-induced Changes in the Plasma Binding of Basic Drugs , 1980, Clinical pharmacokinetics.

[2]  P. Routledge The plasma protein binding of basic drugs. , 1986, British journal of clinical pharmacology.

[3]  A. Wilson,et al.  Studies on the persistence of basic amines in the rabbit lung. , 1979, Drug metabolism and disposition: the biological fate of chemicals.

[4]  T. Orton,et al.  Xenobiotic accumulation and metabolism by isolated perfused rabbit lungs. , 1973, The Journal of pharmacology and experimental therapeutics.

[5]  C A Dawson,et al.  First Pass Uptake of Fentanyl, Meperidine, and Morphine in the Human Lung , 1987, Anesthesiology.

[6]  T. Orton,et al.  Accumulation of amines in the isolated perfused rabbit lung. , 1974, The Journal of pharmacology and experimental therapeutics.

[7]  A. Junod MECHANISMS OF DRUG ACCUMULATION IN THE LUNG , 1975 .

[8]  C. N. Gillis,et al.  Indicator dilution measurement of 5-hydroxytryptamine clearance by human lung. , 1979, Journal of applied physiology: respiratory, environmental and exercise physiology.

[9]  D. Geddes,et al.  First pass uptake of 14C-propranolol by the lung. , 1979, Thorax.

[10]  N. M. Greene,et al.  Pulmonary Extraction of 5‐Hydroxytryptamine and Norepinephrine before and after Cardiopulmonary Bypass in Man , 1972, Circulation research.

[11]  T. Orton,et al.  A study of the dynamics of imipramine accumulation in the isolated perfused rabbit lung. , 1975, Drug metabolism and disposition: the biological fate of chemicals.

[12]  C. Dawson,et al.  Uptake and efflux of 1-alpha-acetylmethadol (LAAM) and methadone in the isolated perfused rat lung. , 1982, Drug metabolism and disposition: the biological fate of chemicals.

[13]  N. M. Greene,et al.  Removal of 5-hydroxytryptamine and norepinephrine from the pulmonary vascular space of man: influence of cardiopulmonary bypass and pulmonary arterial pressure on these processes. , 1974, Surgery.

[14]  L. Jorfeldt,et al.  Lung Uptake of Lidocaine in Healthy Volunteers , 1979, Acta anaesthesiologica Scandinavica.

[15]  B. Brodie,et al.  KINETICS OF PENETRATION OF DRUGS AND OTHER FOREIGN COMPOUNDS INTO CEREBROSPINAL FLUID AND BRAIN , 1959 .

[16]  D A Rickaby,et al.  Influence of plasma protein on the inhibitory effects of indocyanine green and bromcresol green on pulmonary prostaglandin E1 extraction , 1984, British journal of pharmacology.

[17]  D. Lewis,et al.  Lung Uptake of Lidocaine in Man as Influenced by Anaesthesia, Mepivacaine Infusion or Lung Insufficiency , 1983, Acta anaesthesiologica Scandinavica.

[18]  A. Wilson,et al.  Uptake, metabolism and efflux of methadone in "single pass" isolated perfused rabbit lungs. , 1976, The Journal of pharmacology and experimental therapeutics.

[19]  A. Junod,et al.  Uptake, release and metabolism of drugs in the lungs. , 1976, Pharmacology & therapeutics. Part B: General & systematic pharmacology.